HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Henri L. Porte Alain J. Wurtz Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Porte, H. L. Articles by Wurtz, A. J. Search for Related Content PubMed PubMed Citation Articles by Porte, H. L. Articles by Wurtz, A. J.

Eur J Cardiothorac Surg 1999;16:287-291
© 1999 Elsevier Science NL

Pericardoscopy for primary management of pericardial effusion in cancer patients

^a Division of Thoracic Surgery, Calmette Hospital Lille University Hospital, Rue du Pr J. Leclerc 59037 Lille Cedex, France
^b C Division of Cardiology, Heart Hospital Lille University Hospital, Rue du Pr J. Leclerc 59037 Lille Cedex, France

Corresponding author. Clinique Chirurgicale, Hôpital Calmette, Bd du Pr J. Leclercq, 59037 Lille Cedex, France. Tel.:+33-320-44-4559; fax: +33-320-44-4890

Objective: To assess the usefulness of pericardoscopy via the subxyphoid route for the diagnosis and treatment of pericardial effusion in patients with a history of cancer. Methods: All patients with a recent or remote history of cancer and a pericardial effusion of unknown origin requiring drainage for diagnostic and therapeutic purposes were included in the study. They underwent complete exploration and cleansing of the pericardial cavity. Abnormal structures or deposits were biopsied under direct visual control, with a 24 cm long rigid pericardoscope. Results: Between 1985 and 1998, pericardoscopy was completed in 112 of the 114 patients included (feasibility 98 %), resulting in the immediate relief of symptoms in all the cases. Peri-operative mortality was 3.5%, and post-operative morbidity, 6.1%. After pericardioscopy pericardial effusions were considered malignant in 43 cases. One more case (2.3%) due to a false negative result of perycardioscopy was diagnosed during follow-up. Overall, 44 of the 114 patients (38.6%) had a malignant effusion, and 70 (61.4%), a non-malignant effusion according the follow up. In 10 of the 44 patients with a malignant pericardial effusion (22.7%), pericardoscopy corrected the results of cytological pericardial fluid studies and pericardial window biopsy, both false negatives. The sensitivities of cytological studies of the pericardial fluid, pathological examinations of pericardial window biopsy and pericardioscopy were 75, 65 and 97%, respectively. One patient with a malignant effusion had a non-symptomatic recurrence 1 month after pericardioscopy (2.3%). Conclusion: We recommend pericardioscopy to ascertain the malignant nature of the effusion and to diminish the recurrence rate, this avoiding repeat procedures in patients with a short life expectancy.

Key Words: Malignant pericardial effusion • Lung cancer • Non-Hodgkin lymphoma • Pericardioscopy

This article has been cited by other articles:

				J. Soler-Soler and J. Sagristà-Sauleda CHAPTER 19 Pericardial Disease ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF]

				M. Liberman, C. Labos, J. S. Sampalis, N. M. Sheiner, and D. S. Mulder Ten-Year Surgical Experience With Nontraumatic Pericardial Effusions: A Comparison Between the Subxyphoid and Transthoracic Approaches to Pericardial Window Arch Surg, February 1, 2005; 140(2): 191 - 195. [Abstract] [Full Text] [PDF]

				Task Force members, B. Maisch, P. M. Seferovic, A. D. Ristic, R. Erbel, R. Rienmuller, Y. Adler, W. Z. Tomkowski, G. Thiene, M. H. Yacoub, et al. Guidelines on the Diagnosis and Management of Pericardial Diseases Executive Summary: The Task Force on the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology Eur. Heart J., April 1, 2004; 25(7): 587 - 610. [Full Text] [PDF]

				B. Maisch and A. D Ristic Practical aspects of the management of pericardial disease Heart, September 1, 2003; 89(9): 1096 - 1103. [Full Text] [PDF]

				A. J. Wurtz Remarks about usefulness of videothoracoscopic intrapericardial examination of pulmonary vessels to assess the resectability of clinical T4 lung cancer Ann. Thorac. Surg., July 1, 2003; 76(1): 342 - 342. [Full Text] [PDF]

				P. M. Seferovic, A. D. Ristic, R. Maksimovic, V. Tatic, M. Ostojic, and V. Kanjuh Diagnostic Value of Pericardial Biopsy: Improvement With Extensive Sampling Enabled by Pericardioscopy Circulation, February 25, 2003; 107(7): 978 - 983. [Abstract] [Full Text] [PDF]

				H. Porte, D. Metois, L. Finzi, G. Lebuffe, A. Guidat, M. Conti, and A. Wurtz Superior vena cava syndrome of malignant origin. Which surgical procedure for which diagnosis? Eur. J. Cardiothorac. Surg., April 1, 2000; 17(4): 384 - 388. [Abstract] [Full Text] [PDF]